This week, in a letter to Senate Majority Leader Chuck Schumer, AdvaMed® President and CEO Scott Whitaker underscored the critical importance of passing a tax provision that allows small businesses…
AdvaMed, The Medtech Association®, released the following statement thanking the FDA Center for Radiological Health (CDRH) for recently hosting an event in New Delhi to discuss regulatory policies and best practices for ensuring…
AdvaMed, The Medtech Association®, unveiled a timer on the organization’s website to track the number of days since the Centers for Medicare and Medicaid Services (CMS) ended the coverage pathway…
Today, Zach Rothstein, Executive Director of AdvaMedDx®, testified before the House Energy and Commerce Committee, Subcommittee on Health during a hearing on diagnostic test regulation and FDA’s proposed laboratory developed…
Today, AdvaMed, The Medtech Association®, announced Board Chairman Peter Arduini’s priorities to guide the vision of the medtech industry over the course of his two-year term. The priorities, which are…
AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker regarding the conclusion of the World Trade Organization Ministerial conference in Abu Dhabi.
Scott Whitaker, President and CEO of AdvaMed, The Medtech Association®, sent a letter to CMS Administrator Chiquita Brooks-LaSure outlining industry disappointment in the lack of a finalized rule for Transitional…
By Friday, March 1, the Environmental Protection Agency is expected to finalize its regulation for the ethylene oxide (EtO) sterilization of 20 billion, or half, of all medical devices in…
Today, AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on the potential government shutdown and the impact it could have on patients:
Today, AdvaMed, The Medtech Association®, released the newest episode of Medtech POV with Scott Whitaker, featuring a conversation with former Senator Richard Burr of North Carolina.